Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
Ziihera can now be used as an initial treatment for all HER2-positive gastroesophageal adenocarcinomas, dramatically expanding the drug’s market potential.
Original title: “New Jazz cancer drug approval could drive blockbuster sales”
fatal esophageal adenocarcinoma in a pregnant woman mimicking gestational hyperemesis
Original title: “Fatal esophageal adenocarcinoma in a pregnant woman mimicking gestational hyperemesis.”
recurrent steroid responsive exophthalmos as a paraneoplastic manifestation of esophageal adenocarcinoma
Original title: “Recurrent Steroid-Responsive Exophthalmos as a Paraneoplastic Manifestation of Esophageal Adenocarcinoma.”